Solvotrin Therapeutics raised €6.7M in a funding round in Nov 2020. The company is based in Cork, Ireland. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €6.7M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
No investors disclosed for this round.
This is the company's only recorded round.
